{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:23:18Z","timestamp":1789010598162,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.disamonth.2022.101355","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:29:51Z","timestamp":1648848591000},"page":"101355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["An updated narrative review on the management of the most common oncological and hematological emergencies"],"prefix":"10.1016","volume":"69","author":[{"given":"Ali","family":"Issani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.disamonth.2022.101355_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/19371918.2020.1824844","article-title":"Oncological emergencies from pathophysiology and diagnosis to treatment: a narrative review","volume":"35","author":"Jafari","year":"2020","journal-title":"Soc Work Public Health"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101355_bib0002","first-page":"741","article-title":"Oncologic emergencies: recognition and initial management","volume":"97","author":"Higdon","year":"2018","journal-title":"Am Fam Phys"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0885066618803863","article-title":"Oncologic emergencies-the old, the new, and the deadly","volume":"35","author":"Thandra","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101355_bib0004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.mayocp.2017.02.008","article-title":"Emergencies in hematology and oncology","volume":"92","author":"Halfdanarson","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccc.2020.08.004","article-title":"Oncologic emergencies: traditional and contemporary","volume":"37","author":"Spring","year":"2021","journal-title":"Crit Care Clin"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101355_bib0006","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1055\/a-1049-0647","article-title":"Pathophysiology and management of hypercalcemia in malignancy: a review of the literature","volume":"51","author":"Asonitis","year":"2019","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101355_bib0007","first-page":"377","article-title":"Hypercalcemia and cancer: differential diagnosis and treatment","volume":"68","author":"Zagzag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101355_bib0008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12032-019-1315-8","article-title":"Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis [published correction appears in Med Oncol. 2019 Nov 1;36(12):100]","volume":"36","author":"Bhandari","year":"2019","journal-title":"Med Oncol"},{"key":"10.1016\/j.disamonth.2022.101355_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000491040","article-title":"Nonparathyroid hypercalcemia","volume":"51","author":"Goltzman","year":"2019","journal-title":"Front Horm Res"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7861\/clinmedicine.17-3-270","article-title":"Hypercalcaemia - presentation and management","volume":"17","author":"Turner","year":"2017","journal-title":"Clin Med"},{"key":"10.1016\/j.disamonth.2022.101355_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110149","article-title":"Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy","volume":"143","author":"Sheehan","year":"2020","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101355_bib0012","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1210\/clinem\/dgz278","article-title":"Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors","volume":"105","author":"Chukir","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12020-020-02324-2","article-title":"Diagnosis and management of hypocalcemia","volume":"69","author":"Pepe","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.disamonth.2022.101355_bib0014","series-title":"StatPearls. Treasure Island (FL)","article-title":"Calcium","author":"Drake","year":"2021"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101355_bib0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5811\/westjem.2018.12.37335","article-title":"Diagnosis and management of oncologic emergencies","volume":"20","author":"Klemencic","year":"2019","journal-title":"West J Emerg Med"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101355_bib0016","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1177\/1078155218812945","article-title":"A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy","volume":"25","author":"Kim","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0017","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1542\/pir.2018-0243","article-title":"Tumor lysis syndrome","volume":"41","author":"Russell","year":"2020","journal-title":"Pediatr Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101355_bib0018","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/hon.2668","article-title":"Current understanding of tumor lysis syndrome","volume":"37","author":"Rahmani","year":"2019","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0019","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5858\/arpa.2017-0278-RS","article-title":"Tumor lysis syndrome","volume":"143","author":"Williams","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.disamonth.2022.101355_bib0020","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-8-2","article-title":"Tumor lysis syndrome in childhood malignancies","volume":"9","author":"Cheung","year":"2020","journal-title":"Drugs Context"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.JAA.0000723908.23506.85","article-title":"Managing tumor lysis syndrome","volume":"34","author":"Greguska","year":"2021","journal-title":"JAAPA"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0022","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.hoc.2017.08.002","article-title":"Oncologic metabolic emergencies","volume":"31","author":"Wagner","year":"2017","journal-title":"Hematol Oncol Clin N Am"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101355_bib0023","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.21873\/anticanres.12817","article-title":"Metastatic spinal cord compression: unraveling the diagnostic and therapeutic challenges","volume":"38","author":"Boussios","year":"2018","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101355_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2019.0399","article-title":"Metastatic spinal cord compression","volume":"81","author":"Patnaik","year":"2020","journal-title":"Br J Hosp Med"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1200\/JCO.2018.78.1211","article-title":"Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review","volume":"37","author":"Lawton","year":"2019","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.disamonth.2022.101355_bib0026","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1516539","article-title":"Acute spinal cord compression","volume":"376","author":"Ropper","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101355_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4997\/jrcpe.2019.217","article-title":"Malignant spinal cord compression","volume":"49","author":"Macdonald","year":"2019","journal-title":"J R Coll Physicians Edinb"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0028","doi-asserted-by":"crossref","first-page":"e04179","DOI":"10.1002\/ccr3.4179","article-title":"Advanced lung cancer presenting with malignant pericardial effusion","volume":"9","author":"Sadiq","year":"2021","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0029","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s13256-021-03085-w","article-title":"Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: a case report","volume":"15","author":"Neves","year":"2021","journal-title":"J Med Case Rep"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101355_bib0030","first-page":"515","article-title":"Pericardial Effusion","volume":"35","author":"Azarbal","year":"2017","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.disamonth.2022.101355_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjcard.2020.12.092","article-title":"Pericardial involvement in cancer","volume":"145","author":"Chahine","year":"2021","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.disamonth.2022.101355_bib0032","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.jcin.2020.08.038","article-title":"Superior vena cava syndrome","volume":"13","author":"Azizi","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0033","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1024\/0301-1526\/a000908","article-title":"Superior vena cava syndrome","volume":"49","author":"Klein-Weigel","year":"2020","journal-title":"Vasa"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0034","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.emc.2018.04.011","article-title":"Rapid fire: superior vena cava syndrome","volume":"36","author":"Zimmerman","year":"2018","journal-title":"Emerg Med Clin N Am"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101355_bib0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/qjmed\/hcz055","article-title":"Superior vena cava syndrome","volume":"112","author":"Horiuchi","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.disamonth.2022.101355_bib0036","doi-asserted-by":"crossref","DOI":"10.1590\/1677-5449.180062","article-title":"Superior vena cava syndrome: endovascular management","volume":"18","author":"Karakhanian","year":"2019","journal-title":"J Vasc Bras"},{"key":"10.1016\/j.disamonth.2022.101355_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100970","article-title":"Endovascular therapy for superior vena cava syndrome: a systematic review and meta-analysis","volume":"37","author":"Azizi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.disamonth.2022.101355_bib0038","series-title":"StatPearls","article-title":"Superior vena cava syndrome","author":"Seligson","year":"2021"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101355_bib0039","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1016\/j.clml.2020.06.016","article-title":"Ixazomib treatment of IgA multiple myeloma with hyperviscosity syndrome","volume":"20","author":"Boiten","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0040","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.hoc.2017.08.001","article-title":"Oncologic mechanical emergencies","volume":"31","author":"Khan","year":"2017","journal-title":"Hematol Oncol Clin N Am"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101355_bib0041","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3899\/jrheum.200591","article-title":"Hyperviscosity syndrome in rheumatoid arthritis","volume":"48","author":"Miller","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101355_bib0042","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fonc.2020.00815","article-title":"Hyperviscosity syndrome in paraprotein secreting conditions including waldenstrom macroglobulinemia","volume":"10","author":"Weaver","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101355_bib0043","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/qjmed\/hcab175","article-title":"Hyperviscosity syndrome in IgA multiple myeloma","volume":"115","author":"Halaseh","year":"2022","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101355_bib0044","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5811\/westjem.2018.12.37335","article-title":"Diagnosis and management of oncologic emergencies","volume":"20","author":"Klemencic","year":"2019","journal-title":"West J Emerg Med"},{"issue":"13","key":"10.1016\/j.disamonth.2022.101355_bib0045","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2018-06-846816","article-title":"Acute hyperviscosity: syndromes and management","volume":"132","author":"Gertz","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0046","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.emc.2018.04.005","article-title":"Rapid fire: acute blast crisis\/hyperviscosity syndrome","volume":"36","author":"Emerson","year":"2018","journal-title":"Emerg Med Clin N Am"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0047","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000475491","article-title":"Cardiovascular oncologic emergencies","volume":"138","author":"Shenoy","year":"2017","journal-title":"Cardiology"},{"issue":"8","key":"10.1016\/j.disamonth.2022.101355_bib0048","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjmed.2018.02.022","article-title":"Blood is thicker: hyperviscosity syndrome","volume":"131","author":"Geha","year":"2018","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101355_bib0049","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/1573396314666180508121625","article-title":"Febrile neutropenia in children with cancer: approach to diagnosis and treatment","volume":"14","author":"Kebudi","year":"2018","journal-title":"Curr Pediatr Rev"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101355_bib0050","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jamaoncol.2017.1114","article-title":"Febrile neutropenia","volume":"3","author":"Patel","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0051","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1590\/0034-7167-2016-0247","article-title":"Managing febrile neutropenia in adult cancer patients: an integrative review of the literature","volume":"70","author":"Ferreira","year":"2017","journal-title":"Rev Bras Enferm"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101355_bib0052","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/14787210.2019.1573670","article-title":"Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation","volume":"17","author":"Schmidt-Hieber","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101355_bib0053","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (how long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"4S","key":"10.1016\/j.disamonth.2022.101355_bib0054","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/SAP.0000000000002098","article-title":"Radiation-induced skin fibrosis: pathogenesis, current treatment options, and emerging therapeutics","volume":"83","author":"Borrelli","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101355_bib0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ncl.2021.01.012","article-title":"Neuro-oncologic emergencies","volume":"39","author":"Threlkeld","year":"2021","journal-title":"Neurol Clin"},{"key":"10.1016\/j.disamonth.2022.101355_bib0056","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcancer.2019.06.012","article-title":"Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: a review","volume":"64","author":"Khan","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101355_bib0057","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.cell.2021.02.011","article-title":"Understanding and treating the inflammatory adverse events of cancer immunotherapy","volume":"184","author":"Dougan","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101355_bib0058","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.disamonth.2022.101355_bib0059","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3352\/jeehp.2020.17.21","article-title":"Guidelines for the management of extravasation","volume":"17","author":"Kim","year":"2020","journal-title":"J Educ Eval Health Prof"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502922000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502922000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:03:08Z","timestamp":1757898188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502922000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0011502922000396"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2022.101355","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated narrative review on the management of the most common oncological and hematological emergencies","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2022.101355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101355"}}